Filter posts

FDA Acts on Biosimilars

The Biologics Price Competition and Innovation Act (BPCIA) deferred to the Food and Drug Administration …

Biosimilars Ahead, Proceed with Caution

By Richard M. Dolinar, M.D., Chairman, Alliance for Safe Biologic Medicines In today‚Äôs budget-constrained world, …

BIO, Here We Come!

Angie Drakulich from PharmaTech Talk writes: Next week is the annual Biotechnology Industry Organization (BIO) …